UroGen Announces ZUSDURI™ Launch is On-Track and Reports Fourth Quarter and Full Year 2025 Financial Results

Commercial launch is on-track for ZUSDURI™, the first and only FDA-approved medication for adults with recurrent low-grade intermediate-risk ...

Essential U.S. Economic Indicators for Investors

Depending upon the selected set of goods and services used, multiple types of inflation values are calculated and tracked as ...
IEEE

Development of Novel Photosensitive Polyimide with $170{ }^{\circ} \mathrm{C}$ Curing Process to Enable Low Warpage and Sub-$\mathbf{2} \mu \mathrm{m}$ Patterning for Rdls in ...

This paper presents the development of a novel alkaline-developable photosensitive polyimide (PI) designed for re-distribution layers in next-generation interposers. To address key challenges such as ...

Mobisoft Infotech Introduces AI-Augmented Engagement Model to Deliver Faster Outcomes with Leaner Teams

New delivery model applies AI across engineering, testing, DevOps, and analytics to improve speed, transparency, and ...